MGX
Metagenomi, Inc. Common Stock
NASDAQ: MGX · HEALTHCARE · BIOTECHNOLOGY
$1.38
+2.22% today
Updated 2026-04-30
Market cap
$55.68M
P/E ratio
—
P/S ratio
2.21x
EPS (TTM)
$-2.36
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Metagenomi, Inc. Common Stock (MGX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-623.00%
ROE
-44.70%
ROA
-22.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $243000.00 | $-21.44M | -59.26% | -9,854.73% | -8,823.87% |
| 2022 | $17.20M | $-43.59M | 89.92% | -259.53% | -253.45% |
| 2023 | $44.76M | $-68.25M | -110.93% | -175.38% | -152.50% |
| 2024 | $52.30M | $-78.06M | 100.00% | -170.00% | -149.26% |
| 2025 | $25.21M | $-87.87M | 78.91% | -380.85% | -348.54% |